Add these 3 ASX medical technology companies to your watch list

The global medical technology industry is worth some US$430 billion. These 3 ASX medical technology companies have promising futures.

| More on:
CSL share price Digitised bubbles of cells representing ASX biotech shares such as CSL

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medical technology is a broad field covering areas like biotechnology, pharmaceuticals, and information technology. Advancements in medical technology improve the way doctors diagnose and treat patients, leading to better health outcomes. The global medical technology industry is worth some US$430 billion and growing. I believe the below 3 ASX medical technology companies have promising futures in the sector.

Pro Medicus Limited (ASX: PME)

Pro Medicus provides imaging software to hospitals, diagnostic imaging groups and healthcare entities. The company currently operates across Australia, Europe and the United States. Its solutions provide medical accounting, clinical reporting, appointment scheduling, and management information applications. The Pro Medicus share price has largely recovered from the March market correction and is trading at $26.57. This is back on par with levels seen in early 2020. Pro Medicus recently signed a $22 million deal with Chicago-based Northwestern Memorial HealthCare which will implement its Visage 7 technology.

MedAdvisor Ltd (ASX: MDR)

MedAdvisor is behind an innovative software that puts a virtual pharmacist on customer smartphones, tablets, and PCs. The software reminds users when to take medications, fill recurring scripts, and even manage the medication of other family members. It connects with local pharmacies, allowing customers to order prescriptions from their phones for collection. The MedAdvisor share price is up 86% from its March low, currently trading at 54 cents. This week MedAdvisor announced a strategic alliance with NASDAQ-listed HMS Holdings Corp  (NASDAQ: HMSY) under which MedAdvisor will integrate with HMS' health engagement platform. This will enable healthcare organisations to proactively communicate with patients, with MedAdvisor to generate revenue from each digital message sent on behalf of HMS' clients.  

Respiri Ltd (ASX: RSH)

Respiri produces medical devices designed to monitor asthma symptoms for use in hospitals and at home. A respiratory eHealth software-as-a-service (SaaS) company, Respiri is seeking to improve the management of asthma, which impacts some 340 million people worldwide. The Respiri share price has increased by 60% to 9 cents a share from a low of 6 cents in May. Last week Respiri announced an agreement with the University of Edinburgh to partner on a new data research centre. The centre will use data collected using Respiri devices to develop innovations in the delivery of care for people with asthma, chronic obstructive pulmonary disease, and respiratory infections. The ASX medical technology company plans to enter the European market in 2021 following its Australian commercial launch in the fourth quarter of the calendar year 2020.

Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of MedAdvisor. The Motley Fool Australia has recommended MedAdvisor and Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why EML, GQG Partners, IGO, and Integrated Research shares are sinking today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of…

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »

A couple stares at the tv in shock, one holding the remote up ready to press.
Mergers & Acquisitions

Telstra share price climbs amid $3.4b Foxtel sale

Who is buying the Foxtel business? Let's find out.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Brokers say these ASX 200 growth stocks could rise 50% to 70%

Analysts think these shares could be dirt cheap and destined to generate big returns.

Read more »

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet
Broker Notes

Why these ASX shares could be top SMSF options in 2025

Analysts are bullish on these high-quality shares. Let's find out why.

Read more »

The words short selling in red against a black background
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Monday

A good start to the week is expected for Aussie investors. Here's what to watch.

Read more »

A businessman compares the growth trajectory of property versus shares.
Opinions

What's the outlook for shares vs. property in 2025?

The experts have put out their new year predictions...

Read more »